Kinarus further strengthens its leadership with two reputed industry experts
EQS Group-News: Kinarus AG / Key word(s): Personnel/Private Equity
26.04.2021 / 07:01
Hari Kumar, former CEO of Adheron Therapeutics, Inc. appointed Chairman of the Board of Directors
Thierry Fumeaux, MD, former member of Swiss National Covid Taskforce, joined Kinarus as new Chief Medical Officer
Basel, Switzerland, April 26, 2021. Kinarus AG, a Swiss clinical-stage biopharmaceutical company and owner of KIN001, a differentiated therapeutic candidate for the treatment of multiple diseases with high unmet need, announced today the appointment of Hari Kumar as Chairman of the Board of Directors and Thierry Fumeaux as Chief Medical Officer.